Prevalence of protease and reverse transcriptase drug resistance mutations over time in drug-naive human immunodeficiency virus type 1-positive individuals in Rio de Janeiro, Brazil

被引:36
作者
Dumans, AT
Soares, MA
Pieniazek, D
Kalish, ML
De Vroey, V
Hertogs, K
Tanuri, A
机构
[1] Univ Fed Rio de Janeiro, Mol Virol Lab, Dept Genet, BR-21944970 Rio De Janeiro, Brazil
[2] Univ Fed Rio de Janeiro, Inst Biomed, Dept Ciencias Morfol, Unidade Genet, BR-21944970 Rio De Janeiro, Brazil
[3] Ctr Dis Control & Prevent, HIV & Retrovirol Branch, Div AIDS STD & TB Lab Res, Atlanta, GA 30333 USA
[4] VIRCO NV, Tibotec, B-2800 Mechelen, Belgium
关键词
D O I
10.1128/AAC.46.9.3075-3079.2002
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The prevalence of mutations that confer resistance to protease inhibitors and to nucleoside and normucleoside reverse transcriptase inhibitors in 49 blood samples from drug-naive human immunodeficiency virus type 1-infected blood donors living in Rio de Janeiro state, Brazil, in 1998 was evaluated genotypically and phenotypically.
引用
收藏
页码:3075 / 3079
页数:5
相关论文
共 35 条
[1]   HIV-1 drug resistance in newly infected individuals [J].
Boden, D ;
Hurley, A ;
Zhang, LQ ;
Cao, YZ ;
Guo, Y ;
Jones, E ;
Tsay, J ;
Ip, J ;
Farthing, C ;
Limoli, K ;
Parkin, N ;
Markowitz, M .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 282 (12) :1135-1141
[2]   Resistance to antiretroviral drugs in patients with primary HIV-1 infection [J].
Brenner, B ;
Wainberg, MA ;
Salomon, H ;
Rouleau, D ;
Dascal, A ;
Spira, B ;
Sekaly, RP ;
Conway, B ;
Routy, JP .
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2000, 16 (04) :429-434
[3]   Sequence diversity of the reverse transcriptase of human immunodeficiency virus type 1 from untreated Brazilian individuals [J].
Brindeiro, R ;
Vanderborght, B ;
Caride, E ;
Correa, L ;
Oravec, RM ;
Berro, O ;
Stuyver, L ;
Tanuri, A .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (07) :1674-1680
[4]   Primary genotypic and phenotypic HIV-1 drug resistance in recent seroconverters in Madrid [J].
Briones, C ;
Pérez-Olmeda, M ;
Rodríguez, C ;
del Romero, J ;
Hertogs, K ;
Soriano, V .
JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2001, 26 (02) :145-150
[5]   Drug resistance patterns, genetic subtypes, clinical features, and risk factors in military personnel with HIV-1 seroconversion [J].
Brodine, SK ;
Shaffer, RA ;
Starkey, MJ ;
Tasker, SA ;
Gilcrest, JL ;
Louder, MK ;
Barile, A ;
VanCott, TC ;
Vahey, MT ;
McCutchan, FE ;
Birx, DL ;
Richman, DD ;
Mascola, JR .
ANNALS OF INTERNAL MEDICINE, 1999, 131 (07) :502-+
[6]   Reduced susceptibility of human immunodeficiency virus type 1 (HIV-1) from patients with primary HIV infection to nonnucleoside reverse transcriptase inhibitors is associated with variation at novel amino acid sites [J].
Brown, AJL ;
Precious, HM ;
Whitcomb, JM ;
Wong, JK ;
Quigg, M ;
Huang, W ;
Daar, ES ;
D'Aquila, RT ;
Keiser, PH ;
Connick, E ;
Hellmann, NS ;
Petropoulos, CJ ;
Richman, DD ;
Little, SJ .
JOURNAL OF VIROLOGY, 2000, 74 (22) :10269-10273
[7]  
Couto-Fernandez JC, 1999, J ACQ IMMUN DEF SYND, V22, P288
[8]   Analysis of HIV type 1 protease and reverse transcriptase sequences from Venezuela for drug resistance-associated mutations and subtype classification:: A UNAIDS study [J].
Delgado, E ;
León-Ponte, M ;
Villahermosa, ML ;
Cuevas, MT ;
Deibis, L ;
Echeverría, G ;
Thomson, MM ;
Pérez-Alvarez, L ;
Osmanov, S ;
Nájera, R .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 2001, 17 (08) :753-758
[9]   Prevalence of resistance mutations in antiretroviral-naive chronically HIV-infected patients in 1998:: a French nationwide study [J].
Descamps, D ;
Calvez, V ;
Izopet, J ;
Bluffet-Janvresse, C ;
Schmuck, A ;
Colson, P ;
Ruffault, A ;
Maillard, A ;
Masquelier, B ;
Cottalorda, J ;
Harzic, M ;
Brun-Vézinet, F ;
Costagliola, D .
AIDS, 2001, 15 (14) :1777-1782
[10]   Frequency of genotypic and phenotypic drug-resistant HIV-1 among therapy-naive patients of the German Seroconverter Study [J].
Duwe, S ;
Brunn, M ;
Altmann, D ;
Hamouda, O ;
Schmidt, B ;
Walter, H ;
Pauli, G ;
Kücherer, C .
JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2001, 26 (03) :266-273